A1RG34:BVMF
Argenx Se Bdr
220,00 BRL
0,00%
(0,00) 1D
18-ноя., 13:33:57 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Mkt. cap
59,48 млд
Avg. vol.
52,00
Volume
0,00
52-wk high
222,17 BRL
52-wk low
143,22 BRL
Shares outstanding
62,89 млн
No. of employees
2 миң
Mkt. cap
59,48 млд
Avg. vol.
52,00
Volume
0,00
52-wk high
222,17 BRL
52-wk low
143,22 BRL
Shares outstanding
62,89 млн
No. of employees
2 миң
News stories
From web sources and news partners
Yahoo! Finance Canada
·
2 күн мурун
Cradle's Antibody Discovery Platform for Autoimmune Diseases Supports Scientific Mission of argenx
Investing.com
·
2 күн мурун
argenx at Jefferies Global Healthcare Conference: growth plan widens
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr
CEO-
Employees1,86 миң
Founded2008-ж., 25-апр.
Headquarters-
SectorHealth Care
Industry-
Websiteargenx.com